Month: <span>July 2022</span>

Home / 2022 / July
A type of ‘step therapy’ is an effective strategy for diabetic eye disease
Post

A type of ‘step therapy’ is an effective strategy for diabetic eye disease

NIH/NATIONAL EYE INSTITUTE IMAGE: DR. CHIRAG JHAVERI WITH A PATIENT. CREDIT: IMAGE COURTESY OF CHIRAG JHAVERI. Clinical trial results from the DRCR Retina Network suggest that a specific step strategy, in which patients with diabetic macular edema start with a less expensive medicine and switch to a more expensive medicine if vision does not improve...

New stem cell mechanism discovered in the gut
Post

New stem cell mechanism discovered in the gut

by  Institute of Science and Technology Austria Stem cells divide at the bottom of the intestinal crypts and the resulting cells are pushed upwards to the top pf the villi where they are discarded. Credit: © Shutterstock A special layer of cells that coats the insides of the small and large intestines takes in nutrients and...

Post

Study results challenge current thinking about autosomal dominant polycystic kidney disease

AMERICAN SOCIETY OF NEPHROLOGY Highlight New research indicates that the polycystin-2 protein in cells’ endoplasmic reticulum is important for maintaining kidney health, and its lack can contribute to autosomal dominant polycystic kidney disease. Washington, DC (July 12, 2022) — Autosomal dominant polycystic kidney disease (ADPKD) is a common genetic condition that can lead to kidney failure...

Microparticles could be used to deliver ‘self-boosting’ vaccines
Post

Microparticles could be used to deliver ‘self-boosting’ vaccines

by Massachusetts Institute of Technology MIT researchers have developed microparticles that can be tuned to deliver their payload at different time points, which could be used to create “self-boosting” vaccines. Credit: Second Bay Studios, edited by MIT News Most vaccines, from measles to COVID-19, require a series of multiple shots before the recipient is considered...

Genetic discovery to improve lung cancer treatment
Post

Genetic discovery to improve lung cancer treatment

by Edith Cowan University Associate Professor Elin Gray. Credit: Edith Cowan University Lung cancer is the deadliest form of cancer, accounting for an estimated 1.8 million deaths worldwide. Treatment for the condition has improved in recent years—and a new Edith Cowan University study has found how to make it even more effective.  Immunotherapy has emerged...

CRISPR technology highlights genes that contribute to the development of emphysema and COPD
Post

CRISPR technology highlights genes that contribute to the development of emphysema and COPD

by Boston Medical Center Overview of CRISPRi platform to interrogate COPD GWAS genes. (A) Gene editing strategy to generate inducible CRISPRi iPSC/ESC lines with an NKX2-1–GFP and/or SFTPC-tdTomato reporter. (B) Schematic representation of dox-inducible dCas9-KRAB expression and lentiviral-delivered gRNA targeted to the transcriptional start site (TSS) of genes of interest (GOI) to mediate knockdown. (C)...

US regulators OK new COVID-19 shot option from Novavax
Post

US regulators OK new COVID-19 shot option from Novavax

by LAURAN NEERGAARD  In this image provided by the Serum Institute of India, vials of freshly manufactured Novavax COVID-19 vaccines wait to be labeled in 2022, in Pune, India. The U.S. is getting another COVID-19 vaccine choice as the Food and Drug Administration on Wednesday, July 13, 2022, cleared Novavax shots for adults. Credit: Serum...

Virtual Reality App trial shown to reduce common phobias
Post

Virtual Reality App trial shown to reduce common phobias

by University of Otago Adam Hutchinson (left) and Associate Professor Cameron Lacey. Credit: University of Otago Results from a University of Otago, Christchurch trial suggest fresh hope for the estimated one-in-twelve people worldwide suffering from a fear of flying, needles, heights, spiders and dogs. The trial, led by Associate Professor Cameron Lacey, from the Department...

Established drug for symptoms of angina pectoris also protects vascular system
Post

Established drug for symptoms of angina pectoris also protects vascular system

by Johannes Angerer, Medical University of Vienna Plaque burden and morphology in ranolazine-treated LDL receptor knockout mice. Plaque burden and composition was analyzed in 25 LDL-R knockout mice (n = 12 ranolazine and n = 13 control). Overall plaque burden was evaluated using en face staining of the total aorta (A). Aortic roots were stained...